article · BMJ Global Health

Ten-year health impact, economic impact and return on investment of the South African molecular diagnostics programme for HIV, tuberculosis and SARS-CoV-2

Brooke E Nichols
Kyra H. Grantz
Naseem Cassim
Alvin X. Han
Lesley Scott
Lucia Hans
Lise Jamieson
Pedro Da Silva
Kamy Chetty
Alexandra de Nooy
Andrew Phillips
Wendy Stevens

20241 citationOpen accessStellenbosch University

Abstract

The molecular diagnostics programme in South Africa generated a significant amount of health gains and economic value associated with these health gains. The return on investment rivals other high-impact public health interventions such as childhood vaccination. The molecular diagnostics programme in South Africa is highly impactful and will continue to be an excellent investment in South African public health expenditure.

Research topics

HIV/AIDS Impact and Responses
Global Public Health Policies and Epidemiology
Global Health and Surgery

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

View on publisher site Record on OpenAlex

DOI: 10.1136/bmjgh-2024-015830

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.

New to MARATTO™? Create a free account.